Living in the liver: hepatic infections (original) (raw)

• Thomson, A. W. & Knolle, P. A. Antigen-presenting cell function in the tolerogenic liver environment. Nature Rev. Immunol. 10, 753–766 (2010).
  Article CAS Google Scholar
• Schlepper-Schafer, J. et al. Endocytosis via galactose receptors in vivo. Ligand size directs uptake by hepatocytes and/or liver macrophages. Exp. Cell Res. 165, 494–506 (1986).
  Article CAS PubMed Google Scholar
• Wisse, E., De Zanger, R. B., Charels, K., Van Der Smissen, P. & McCuskey, R. S. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 5, 683–692 (1985).
  Article CAS PubMed Google Scholar
• Tavassoli, M., Kishimoto, T., Soda, R., Kataoka, M. & Harjes, K. Liver endothelium mediates the uptake of iron–transferrin complex by hepatocytes. Exp. Cell. Res. 165, 369–379 (1986).
  Article CAS PubMed Google Scholar
• Mostov, K. E. Transepithelial transport of immunoglobulins. Annu. Rev. Immunol. 12, 63–84 (1994).
  Article CAS PubMed Google Scholar
• Middleton, J. et al. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91, 385–395 (1997).
  Article CAS PubMed Google Scholar
• Smedsrod, B. Clearance function of scavenger endothelial cells. Comp. Hepatol. 3, S22 (2004).
  Article PubMed PubMed Central Google Scholar
• Pradel, G. & Frevert, U. Malaria sporozoites actively enter and pass through rat Kupffer cells prior to hepatocyte invasion. Hepatology 33, 1154–1165 (2001). The first report showing that sporozoites target Kupffer cells to overcome the sinusoidal barrier.
  Article CAS PubMed Google Scholar
• Ishino, T., Yano, K., Chinzei, Y. & Yuda, M. Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer. PLoS Biol. 2, e4 (2004).
  Article PubMed PubMed Central CAS Google Scholar
• Baer, K. et al. Kupffer cells are obligatory for Plasmodium yoelii sporozoite infection of the liver. Cell. Microbiol. 9, 397–412 (2007).
  Article CAS PubMed Google Scholar
• Mota, M. M., Hafalla, J. C. & Rodriguez, A. Migration through host cells activates Plasmodium sporozoites for infection. Nature Med. 8, 1318–1322 (2002).
  Article CAS PubMed Google Scholar
• Coppi, A. et al. The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host. J. Exp. Med. 208, 341–356 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Silvie, O. et al. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nature Med. 9, 93–96 (2003).
  Article CAS PubMed Google Scholar
• Sturm, A. et al. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313, 1287–1290 (2006).
  Article CAS PubMed Google Scholar
• Bartenschlager, R., Penin, F., Lohmann, V. & Andre, P. Assembly of infectious hepatitis C virus particles. Trends Microbiol. 19, 95–103 (2011).
  Article CAS PubMed Google Scholar
• Bashirova, A. A. et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J. Exp. Med. 193, 671–678 (2001).
  Article PubMed PubMed Central CAS Google Scholar
• Lai, W. K. et al. Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium: a role for capturing hepatitis C virus particles. Am. J. Pathol. 169, 200–208 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Gardner, J. P. et al. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc. Natl Acad. Sci. USA 100, 4498–4503 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Pohlmann, S. et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J. Virol. 77, 4070–4080 (2003). References 18 and 19 were the first two reports on the potential role of L-SIGN and DC-SIGN in liver infection by HCV.
  Article PubMed PubMed Central CAS Google Scholar
• Geijtenbeek, T. B. et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100, 587–597 (2000).
  Article CAS PubMed Google Scholar
• Pileri, P. et al. Binding of hepatitis C virus to CD81. Science 282, 938–941 (1998).
  Article CAS PubMed Google Scholar
• Agnello, V., Abel, G., Elfahal, M., Knight, G. B. & Zhang, Q. X. Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl Acad. Sci. USA 96, 12766–12771 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Scarselli, E. et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21, 5017–5025 (2002).
  Article PubMed PubMed Central CAS Google Scholar
• Evans, M. J. et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446, 801–805 (2007).
  Article CAS PubMed Google Scholar
• Ploss, A. et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457, 882–886 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Lupberger, J. et al. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nature Med. 17, 589–595 (2011).
  Article CAS PubMed Google Scholar
• Gripon, P. et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl Acad. Sci. USA 99, 15655–15660 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Blanchet, M. & Sureau, C. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. J. Virol. 80, 11935–11945 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Salisse, J. & Sureau, C. A function essential to viral entry underlies the hepatitis B virus “a” determinant. J. Virol. 83, 9321–9328 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Petersen, J. et al. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nature Biotech. 26, 335–341 (2008).
  Article CAS Google Scholar
• Schulze, A., Gripon, P. & Urban, S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 46, 1759–1768 (2007).
  Article CAS PubMed Google Scholar
• Jilbert, A. R., Miller, D. S., Scougall, C. A., Turnbull, H. & Burrell, C. J. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks. Virology 226, 338–345 (1996).
  Article CAS PubMed Google Scholar
• Asabe, S. et al. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J. Virol. 83, 9652–9662 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Breiner, K. M., Schaller, H. & Knolle, P. A. Endothelial cell-mediated uptake of a hepatitis B virus: a new concept of liver targeting of hepatotropic microorganisms. Hepatology 34, 803–808 (2001).
  Article CAS PubMed Google Scholar
• Ashida, M. & Hamada, C. Molecular cloning of the hepatitis A virus receptor from a simian cell line. J. Gen. Virol. 78, 1565–1569 (1997).
  Article CAS PubMed Google Scholar
• Kaplan, G. et al. Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J. 15, 4282–4296 (1996).
  Article PubMed PubMed Central CAS Google Scholar
• Feigelstock, D., Thompson, P., Mattoo, P., Zhang, Y. & Kaplan, G. G. The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J. Virol. 72, 6621–6628 (1998).
  PubMed PubMed Central CAS Google Scholar
• van Egmond, M. et al. FcαRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nature Med. 6, 680–685 (2000).
  Article CAS PubMed Google Scholar
• Popov, A. et al. Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J. Clin. Invest. 116, 3160–3170 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Egen, J. G. et al. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 28, 271–284 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Volkman, H. E. et al. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327, 466–469 (2010).
  Article CAS PubMed Google Scholar
• Taylor, J. L. et al. Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect. Immun. 74, 6135–6144 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Davis, J. M. & Ramakrishnan, L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37–49 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Wang, B. et al. Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication. J. Hepatol. 51, 1037–1045 (2009).
  Article CAS PubMed Google Scholar
• Wu, J. et al. Hepatitis B virus suppresses Toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49, 1132–1140 (2009).
  Article CAS PubMed Google Scholar
• Kern, M. et al. Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity. Gastroenterology 138, 336–346 (2010).
  Article CAS PubMed Google Scholar
• Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J. & Gale, M. Jr. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454, 523–527 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Ebert, G. et al. 5′ triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice. Gastroenterology 141, 696–706 (2011).
  Article CAS PubMed Google Scholar
• Seki, E. et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nature Med. 13, 1324–1332 (2007).
  Article CAS PubMed Google Scholar
• Gao, B., Jeong, W. I. & Tian, Z. Liver: an organ with predominant innate immunity. Hepatology 47, 729–736 (2008).
  Article CAS PubMed Google Scholar
• Baumann, H. & Gauldie, J. The acute phase response. Immunol. Today 15, 74–80 (1994).
  Article CAS PubMed Google Scholar
• Wu, J. et al. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 46, 1769–1778 (2007).
  Article CAS PubMed Google Scholar
• Biswas, S. K. & Lopez-Collazo, E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475–487 (2009).
  Article CAS PubMed Google Scholar
• De Creus, A. et al. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J. Immunol. 174, 2037–2045 (2005).
  Article CAS PubMed Google Scholar
• Limmer, A. et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nature Med. 6, 1348–1354 (2000).
  Article CAS PubMed Google Scholar
• Khakoo, S. I. et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872–874 (2004).
  Article CAS PubMed Google Scholar
• Lee, W. Y. et al. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and _i_NKT cells. Nature Immunol. 11, 295–302 (2010). A seminal paper demonstrating the efficient intravascular immune response in the liver against bacteria.
  Article CAS Google Scholar
• Dolganiuc, A. et al. Hepatitis C core and nonstructural 3 proteins trigger Toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127, 1513–1524 (2004).
  Article CAS PubMed Google Scholar
• Cooper, A., Tal, G., Lider, O. & Shaul, Y. Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2. J. Immunol. 175, 3165–3176 (2005).
  Article CAS PubMed Google Scholar
• Hosel, M. et al. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 50, 1773–1782 (2009).
  Article CAS PubMed Google Scholar
• Klein, C. et al. The IL-6–gp130–STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J. Clin. Invest. 115, 860–869 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Gehring, S. et al. Kupffer cells abrogate cholestatic liver injury in mice. Gastroenterology 130, 810–822 (2006).
  Article CAS PubMed Google Scholar
• Dunn, C. et al. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137, 1289–1300 (2009).
  Article CAS PubMed Google Scholar
• Wieland, S., Thimme, R., Purcell, R. H. & Chisari, F. V. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl Acad. Sci. USA 101, 6669–6674 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Gale, M. Jr & Foy, E. M. Evasion of intracellular host defence by hepatitis C virus. Nature 436, 939–945 (2005).
  Article CAS PubMed Google Scholar
• Qu, L. & Lemon, S. M. Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses. Semin. Liver Dis. 30, 319–332 (2010).
  Article CAS PubMed Google Scholar
• Ke, P. Y. & Chen, S. S. Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J. Clin. Invest. 121, 37–56 (2011).
  Article CAS PubMed Google Scholar
• Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell, R. A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732–738 (2001).
  Article CAS PubMed Google Scholar
• Li, X. D., Sun, L., Seth, R. B., Pineda, G. & Chen, Z. J. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl Acad. Sci. USA 102, 17717–17722 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Meylan, E. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167–1172 (2005).
  Article CAS PubMed Google Scholar
• Foy, E. et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300, 1145–1148 (2003). The first report on HCV immune escape blocking IRF3 function.
  Article CAS PubMed Google Scholar
• Yang, Y. et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl Acad. Sci. USA 104, 7253–7258 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Qu, L. et al. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog. 7, e1002169 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Lanford, R. E. et al. Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. Proc. Natl Acad. Sci. USA 108, 11223–11228 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Desai, M. M. et al. Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver. Gastroenterology 141, 674–685 (2011).
  Article PubMed CAS Google Scholar
• Usynin, I., Klotz, C. & Frevert, U. Malaria circumsporozoite protein inhibits the respiratory burst in Kupffer cells. Cell. Microbiol. 9, 2610–2628 (2007).
  Article CAS PubMed Google Scholar
• Torgler, R. et al. Sporozoite-mediated hepatocyte wounding limits Plasmodium parasite development via MyD88-mediated NF-κB activation and inducible NO synthase expression. J. Immunol. 180, 3990–3999 (2008).
  Article CAS PubMed Google Scholar
• Gowda, D. C. TLR-mediated cell signaling by malaria GPIs. Trends Parasitol. 23, 596–604 (2007).
  Article CAS PubMed Google Scholar
• Taniguchi, M., Seino, K. & Nakayama, T. The NKT cell system: bridging innate and acquired immunity. Nature Immunol. 4, 1164–1165 (2003).
  Article CAS Google Scholar
• Swain, M. G. Natural killer T cells within the liver: conductors of the hepatic immune orchestra. Dig. Dis. 28, 7–13 (2010).
  Article CAS PubMed Google Scholar
• Klugewitz, K., Adams, D. H., Emoto, M., Eulenburg, K. & Hamann, A. The composition of intrahepatic lymphocytes: shaped by selective recruitment? Trends Immunol. 25, 590–594 (2004).
  Article CAS PubMed Google Scholar
• Polakos, N. K. et al. Early intrahepatic accumulation of CD8+ T cells provides a source of effectors for nonhepatic immune responses. J. Immunol. 179, 201–210 (2007).
  Article CAS PubMed Google Scholar
• Keating, R. et al. Virus-specific CD8+ T cells in the liver: armed and ready to kill. J. Immunol. 178, 2737–2745 (2007).
  Article CAS PubMed Google Scholar
• Paust, S. et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nature Immunol. 11, 1127–1135 (2010). A demonstration of a population of CXCR6-expressing intrahepatic NK cells able to mediate antigen-specific memory.
  Article CAS Google Scholar
• Schmidt, N. W. et al. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc. Natl Acad. Sci. USA 105, 14017–14022 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Kumar, K. A. et al. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444, 937–940 (2006).
  Article CAS PubMed Google Scholar
• Chakravarty, S. et al. CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nature Med. 13, 1035–1041 (2007). A classical paper reporting extrahepatic priming of sporozoite-specific T cells.
  Article CAS PubMed Google Scholar
• Carvalho, L. H. et al. IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages. Nature Med. 8, 166–170 (2002).
  Article CAS PubMed Google Scholar
• Morrot, A., Hafalla, J. C., Cockburn, I. A., Carvalho, L. H. & Zavala, F. IL-4 receptor expression on CD8+ T cells is required for the development of protective memory responses against liver stages of malaria parasites. J. Exp. Med. 202, 551–560 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Overstreet, M. G., Cockburn, I. A., Chen, Y. C. & Zavala, F. Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response. Immunol. Rev. 225, 272–283 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Cockburn, I. A. et al. Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites. PLoS Pathog. 6, e1000877 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Good, M. F. & Doolan, D. L. Malaria vaccine design: immunological considerations. Immunity 33, 555–566 (2010).
  Article CAS PubMed Google Scholar
• Amadei, B. et al. Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology 138, 1536–1545 (2010).
  Article PubMed CAS Google Scholar
• Canbay, A. et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 38, 1188–1198 (2003).
  Article CAS PubMed Google Scholar
• McDonald, B. et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330, 362–366 (2010).
  Article CAS PubMed Google Scholar
• Lang, P. A. et al. Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology 52, 25–32 (2010).
  Article CAS PubMed Google Scholar
• Schulz, O. et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433, 887–892 (2005).
  Article CAS PubMed Google Scholar
• Sancho, D. et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 458, 899–903 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Veerapu, N. S., Raghuraman, S., Liang, T. J., Heller, T. & Rehermann, B. Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses. Gastroenterology 140, 676–685 (2011).
  Article CAS PubMed Google Scholar
• Rehermann, B., Ferrari, C., Pasquinelli, C. & Chisari, F. V. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nature Med. 2, 1104–1108 (1996). A landmark paper demonstrating that HBV is controlled but not eliminated.
  Article CAS PubMed Google Scholar
• Bertoletti, A. & Ferrari, C. Kinetics of the immune response during HBV and HCV infection. Hepatology 38, 4–13 (2003).
  Article CAS PubMed Google Scholar
• Rehermann, B. & Nascimbeni, M. Immunology of hepatitis B virus and hepatitis C virus infection. Nature Rev. Immunol. 5, 215–229 (2005).
  Article CAS Google Scholar
• Guidotti, L. G. & Chisari, F. V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19, 65–91 (2001). A key review on the non-cytolytic antiviral activity of cytokines in HBV-infected transgenic mice.
  Article CAS PubMed Google Scholar
• Garcia-Rodriguez, M. J., Canales, M. A., Hernandez-Maraver, D. & Hernandez-Navarro, F. Late reactivation of resolved hepatitis B virus infection: an increasing complication post rituximab-based regimens treatment? Am. J. Hematol. 83, 673–675 (2008).
  Article CAS PubMed Google Scholar
• von Hahn, T. et al. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 132, 667–678 (2007).
  Article CAS PubMed Google Scholar
• Brimacombe, C. L. et al. Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission. J. Virol. 85, 596–605 (2011).
  Article CAS PubMed Google Scholar
• Lopes, A. R. et al. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J. Clin. Invest. 118, 1835–1845 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Radziewicz, H. et al. Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection. J. Virol. 82, 9808–9822 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Bowen, D. G. et al. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J. Clin. Invest. 114, 701–712 (2004). A key paper describing that initial priming of T cells in the liver determines the development of peripheral immune tolerance.
  Article PubMed PubMed Central CAS Google Scholar
• Holz, L. E. et al. Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology 135, 989–997 (2008).
  Article PubMed Google Scholar
• Schurich, A. et al. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 53, 1494–1503 (2011).
  Article CAS PubMed Google Scholar
• Larrubia, J. R. et al. Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1+/CD127− HCV-specific CD8+ cells targeting the virus in chronic hepatitis C virus infection. Cell. Immunol. 269, 104–114 (2011).
  Article CAS PubMed Google Scholar
• Tinoco, R., Alcalde, V., Yang, Y., Sauer, K. & Zuniga, E. I. Cell-intrinsic transforming growth factor-β signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. Immunity 31, 145–157 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Benseler, V. et al. Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc. Natl Acad. Sci. USA 108, 16735–16740 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wherry, E. J. T cell exhaustion. Nature Immunol. 12, 492–499 (2011).
  Article CAS Google Scholar
• Iwai, Y., Terawaki, S., Ikegawa, M., Okazaki, T. & Honjo, T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J. Exp. Med. 198, 39–50 (2003). This paper reports the seminal discovery of the essential protective role of PDL1 for the liver.
  Article PubMed PubMed Central CAS Google Scholar
• Dong, H. et al. B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes. Immunity 20, 327–336 (2004).
  Article CAS PubMed Google Scholar
• Isogawa, M., Furuichi, Y. & Chisari, F. V. Oscillating CD8+ T cell effector functions after antigen recognition in the liver. Immunity 23, 53–63 (2005).
  Article CAS PubMed Google Scholar
• Blackburn, S. D. et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nature Immunol. 10, 29–37 (2009). An elegant demonstration of multiple co-inhibitory pathways driving T cell exhaustion.
  Article CAS Google Scholar
• Klenerman, P. & Thimme, R. T cell responses in hepatitis C: the good, the bad and the unconventional. Gut 28 Aug 2011 (doi:10.1136/gutjnl-2011-300620).
• Fisicaro, P. et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 138, 682–693 (2010).
  Article CAS PubMed Google Scholar
• He, X. S. et al. Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide–MHC tetramers. Proc. Natl Acad. Sci. USA 96, 5692–5697 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Maini, M. K. et al. The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191, 1269–1280 (2000).
  Article PubMed PubMed Central CAS Google Scholar
• Bengsch, B. et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog. 6, e1000947 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Blackburn, S. D. et al. Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion. J. Virol. 84, 2078–2089 (2010).
  Article CAS PubMed Google Scholar
• Diehl, L. et al. Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance. Hepatology 47, 296–305 (2008).
  Article CAS PubMed Google Scholar
• Yu, M. C. et al. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 40, 1312–1321 (2004).
  Article CAS PubMed Google Scholar
• Mühlbauer, M. et al. PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis. J. Hepatol. 45, 520–528 (2006).
  Article CAS PubMed Google Scholar
• Zhang, Z. et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 134, 1938–1949 (2008).
  Article PubMed Google Scholar
• Kassel, R. et al. Chronically inflamed livers up-regulate expression of inhibitory B7 family members. Hepatology 50, 1625–1637 (2009).
  Article PubMed Google Scholar
• Mengshol, J. A. et al. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS ONE 5, e9504 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682–687 (2006). A seminal report on the role of PD1 in T cell exhaustion during viral infection.
  Article CAS PubMed Google Scholar
• Doherty, D. G. et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J. Immunol. 163, 2314–2321 (1999).
  CAS PubMed Google Scholar
• Wuensch, S. A., Spahn, J. & Crispe, I. N. Direct, help-independent priming of CD8+ T cells by adeno-associated virus-transduced hepatocytes. Hepatology 52, 1068–1077 (2010).
  Article PubMed CAS Google Scholar
• Raziorrouh, B. et al. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection. Gastroenterology 141, 1422–1431 (2011).
  Article CAS PubMed Google Scholar
• Manigold, T. & Racanelli, V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect. Dis. 7, 804–813 (2007).
  Article CAS PubMed Google Scholar
• Franceschini, D. et al. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J. Clin. Invest. 119, 551–564 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Knolle, P. et al. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J. Hepatol. 22, 226–229 (1995).
  Article CAS PubMed Google Scholar
• Ha, S. J., West, E. E., Araki, K., Smith, K. A. & Ahmed, R. Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections. Immunol. Rev. 223, 317–333 (2008).
  Article CAS PubMed Google Scholar
• Peppa, D. et al. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog. 6, e1001227 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Accapezzato, D. et al. Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection. J. Clin. Invest. 113, 963–972 (2004).
  Article PubMed PubMed Central CAS Google Scholar
• Abel, M. et al. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology 44, 1607–1616 (2006).
  Article CAS PubMed Google Scholar
• Chang, J. J. et al. The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection. Hepatology 46, 1332–1340 (2007).
  Article CAS PubMed Google Scholar
• Chisari, F. V. et al. Production of two distinct and independent hepatic immunoregulatory molecules by the perfused rat liver. Hepatology 5, 735–743 (1985).
  Article CAS PubMed Google Scholar
• Munn, D. H. & Mellor, A. L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 117, 1147–1154 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Larrea, E. et al. Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection. J. Virol. 81, 3662–3666 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Dunn, C. et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 204, 667–680 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Oliviero, B. et al. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137, 1151–1160 (2009).
  Article CAS PubMed Google Scholar
• Tu, Z. et al. TLR-dependent cross talk between human Kupffer cells and NK cells. J. Exp. Med. 205, 233–244 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Sene, D. et al. Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines. PLoS Pathog. 6, e1001184 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Billerbeck, E. et al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc. Natl Acad. Sci. USA 107, 3006–3011 (2010).
  Article PubMed PubMed Central Google Scholar
• de Lalla, C. et al. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J. Immunol. 173, 1417–1425 (2004).
  Article CAS PubMed Google Scholar
• Finlay, B. B. & McFadden, G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124, 767–782 (2006).
  Article CAS PubMed Google Scholar
• Rosen, H. R. Clinical practice. Chronic hepatitis C infection. N. Engl. J. Med. 364, 2429–2438 (2011).
  Article CAS PubMed Google Scholar
• Werle-Lapostolle, B. et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126, 1750–1758 (2004).
  Article CAS PubMed Google Scholar
• Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399–401 (2009).
  Article CAS PubMed Google Scholar
• Tanaka, Y. et al. Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C. Nature Genet. 41, 1105–1109 (2009).
  Article CAS PubMed Google Scholar
• Suppiah, V. et al. IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy. Nature Genet. 41, 1100–1104 (2009).
  Article CAS PubMed Google Scholar
• Han, Q., Zhang, C., Zhang, J. & Tian, Z. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner. Hepatology 54, 1179–1189 (2011).
  Article CAS PubMed Google Scholar
• Bertoletti, A. & Maini, M. K. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr. Opin. Immunol. 12, 403–408 (2000).
  Article CAS PubMed Google Scholar
• Kakimi, K., Guidotti, L. G., Koezuka, Y. & Chisari, F. V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192, 921–930 (2000).
  Article PubMed PubMed Central CAS Google Scholar
• Loggi, E. et al. Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft. J. Hepatol. 50, 625–630 (2009).
  Article PubMed Google Scholar
• Maini, M. K. & Schurich, A. The molecular basis of the failed immune response in chronic HBV: therapeutic implications. J. Hepatol. 52, 616–619 (2010).
  Article CAS PubMed Google Scholar
• Kutscher, S., Bauer, T., Dembek, C., Sprinzl, M. & Protzer, U. Design of therapeutic vaccines: hepatitis B as an example. Microb. Biotechnol. 29 Sep 2011 (doi:10.1111/j.1751-7915.2011.00303.x).
• McCaffrey, A. P. et al. Inhibition of hepatitis B virus in mice by RNA interference. Nature Biotech. 21, 639–644 (2003).
  Article CAS Google Scholar
• Klein, C. et al. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology 125, 9–18 (2003).
  Article CAS PubMed Google Scholar
• Ilan, Y. et al. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. Gastroenterology 104, 1818–1821 (1993).
  Article CAS PubMed Google Scholar
• Hui, C. K. et al. A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation. Blood 106, 464–469 (2005).
  Article CAS PubMed Google Scholar
• Hawkins, R. E. et al. Development of adoptive cell therapy for cancer: a clinical perspective. Hum. Gene Ther. 21, 665–672 (2010).
  Article CAS PubMed Google Scholar
• Protzer, U. & Abken, H. Can engineered “designer” T cells outsmart chronic hepatitis B? Hepat. Res. Treat. 2010, 901216 (2010).
  PubMed PubMed Central CAS Google Scholar
• Gehring, A. J. et al. Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. J. Hepatol. 55, 103–110 (2011).
  Article CAS PubMed Google Scholar
• Bohne, F. et al. T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes. Gastroenterology 134, 239–247 (2008).
  Article CAS PubMed Google Scholar
• Abken, H., Hombach, A. & Heuser, C. Immune response manipulation: recombinant immunoreceptors endow T-cells with predefined specificity. Curr. Pharm. Des. 9, 1992–2001 (2003).
  Article CAS PubMed Google Scholar
• Riddell, S. R. & Protzer, U. Carving the CAR. Gene Ther. 17, 1191–1192 (2010).
  Article CAS PubMed Google Scholar
• Ghiringhelli, F. et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors. Nature Med. 15, 1170–1178 (2009).
  Article CAS PubMed Google Scholar
• Das, A. et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J. Exp. Med. 205, 2111–2124 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Thomas, D. L. et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798–801 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Dazert, E. et al. Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. J. Clin. Invest. 119, 376–386 (2009). An important report demonstrating the link between viral fitness and HLA-B27-restricted T cell immunity.
  PubMed PubMed Central CAS Google Scholar
• Chisari, F. V. & Ferrari, C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13, 29–60 (1995).
  Article CAS PubMed Google Scholar
• Kurts, C., Robinson, B. W. & Knolle, P. A. Cross-priming in health and disease. Nature Rev. Immunol. 10, 403–414 (2010).
  Article CAS Google Scholar
• Wieland, S. F., Spangenberg, H. C., Thimme, R., Purcell, R. H. & Chisari, F. V. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc. Natl Acad. Sci. USA 101, 2129–2134 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Murray, J. M., Wieland, S. F., Purcell, R. H. & Chisari, F. V. Dynamics of hepatitis B virus clearance in chimpanzees. Proc. Natl Acad. Sci. USA 102, 17780–17785 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Summers, J. & Mason, W. S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29, 403–415 (1982).
  Article CAS PubMed Google Scholar